ASHINGTON — Daniel Best is suddenly leading the government’s campaign to bring down prescription drug prices. But nobody around town seems to know the guy.

While he’s a Washington outsider, he’s the very definition of a pharmaceutical industry insider, having spent the last 13 years working for pharmacy benefit managers, the middlemen who negotiate drug prices. Their secretive contracting and business practices have drawn suspicion from lawmakers and administration officials.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Well , It seems to me that Danial Best is the man that can tell all ! Being that PBM’s are the problem to the drug pricing problem , Mr. Best ,without a doubt , should spill the beans on the PBM’s stealing tactics of paying pharmacies below they’re cost , charging pharmacies these d.i.r fees , that are so vague and frankly are not the pharmacies responsibility . PBM’s have
    no governmental agency setting down laws for them to follow . They do whatever they want !!! This is a disgrace , besides the fact that PBM’s want the independent pharmacy out of business !!! And they are accomplishing it !!!

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy